Oxymorphone hydrochloride

Ranbaxy Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 13, 2016
Approval ID: e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde
Products: 7 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OXYMORPHONE hydrochloride Extended-Release Tablets safely and effectively. See full prescribing information for OXYMORPHONE hydrochloride Extended-Release Tablets. OXYMORPHONE hydrochloride Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 1959

Quick Stats

Total Products7

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.